Celine Marmion
#110,612
Most Influential Person Now
Researcher
Celine Marmion's AcademicInfluence.com Rankings
Celine Marmioncomputer-science Degrees
Computer Science
#12899
World Rank
#13823
Historical Rank
Computational Linguistics
#3224
World Rank
#3267
Historical Rank
Machine Learning
#5965
World Rank
#6062
Historical Rank
Artificial Intelligence
#6426
World Rank
#6540
Historical Rank

Download Badge
Computer Science
Celine Marmion's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Celine Marmion Influential?
(Suggest an Edit or Addition)According to Wikipedia, Celine J. Marmion is a Professor of Chemistry at the Royal College of Surgeons in Ireland and President of the Institute of Chemistry of Ireland. She is a Fellow of the Royal Society of Chemistry and the Institute of Chemistry of Ireland. Marmion is involved with the design of new chemotherapeutic drugs.
Celine Marmion's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens? (2019) (312)
- Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands (2004) (143)
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. (2009) (95)
- Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision? (2017) (95)
- Copper complexes as artificial DNA metallonucleases: From Sigman’s reagent to next generation anti-cancer agent? (2017) (77)
- Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes. (2011) (66)
- A novel dual-functioning ruthenium(II)-arene complex of an anti-microbial ciprofloxacin derivative - Anti-proliferative and anti-microbial activity. (2016) (52)
- Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeutics. (2010) (48)
- Hydroxamic acids are nitric oxide donors. Facile formation of ruthenium(II)-nitrosyls and NO-mediated activation of guanylate cyclase by hydroxamic acids (2000) (47)
- Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)]. (2012) (40)
- Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer. (2016) (40)
- Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity. (2011) (38)
- Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation (2008) (37)
- Hydroxamic Acids — An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands (2004) (33)
- Novel platinum(II) ammine hydroxamate and hydroximate complexes and the platinum-assisted hydrolysis of hydroxamic acids. (2005) (29)
- Ruthenium as an effective nitric oxide scavenger. (2004) (28)
- Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium(III) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigations. (2008) (27)
- A novel platinum complex of the histone deacetylase inhibitor belinostat: rational design, development and in vitro cytotoxicity. (2013) (25)
- Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties (2007) (22)
- New tetradentate Schiff bases, their oxovanadium(IV) complexes, and some complexes of bidentate Schiff bases with vanadium(III) (1997) (22)
- Synthesis, characterisation and speciation studies of heterobimetallic pyridinehydroxamate-bridged Pt(II)/M(II) complexes (M = Cu, Ni, Zn). Crystal structure of a novel heterobimetallic 3-pyridinehydroxamate-bridged Pt(II)/Cu(II) wave-like coordination polymer. (2005) (20)
- Novel palladium(II) and platinum(II) complexes of biocidal benzisothiazolinone (Bit); X-ray crystal structures of co-crystallised Bit/BitO and cis-Pd(en)(Bit−1H)2·H2O (2010) (17)
- Innovative DNA-Targeted Metallo-prodrug Strategy Combining Histone Deacetylase Inhibition with Oxidative Stress. (2018) (16)
- Ruthenium(III) readily abstracts NO from L-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthases. (2001) (15)
- Hydroxamic Acids: An Important Class of Metalloenzyme Inhibitors (2013) (15)
- Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors. (2019) (13)
- New compounds containing thetriangulo-trichlorotrivanadium(II) moiety (1997) (12)
- A novel ruthenium nitrosyl complex which also contains a free NO-donor moiety (2004) (11)
- Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum(ii) resulting in a novel platinum(ii)-buforin IIb conjugate with anti-cancer activity. (2016) (11)
- The reduction of platinum(IV) and palladium(IV) ions by 2,6-pyridinedihydroxamic acid. (2008) (10)
- Iron(III) Tris(pyridinehydroxamate)s and Related Nickel(II) and Zinc(II) Complexes: Potential Platforms for the Design of Novel Heterodimetallic Supramolecular Assemblies (2007) (9)
- A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties. (2019) (8)
- Hydroxamic Acids: Chemistry, Bioactivity, and Solutionand Solid‐Phase Synthesis (2010) (6)
- Redetermination of fac-tris(benzohydroxamato)iron(III) trihydrate (2000) (6)
- In-vitro cytotoxicity studies of vanadyl complexes with hydroxamic acid series (2010) (5)
- Non-linear optical measurement of Iron(III) Tris(pyridinehydroxamate) complexes (2012) (5)
- Derivatisation of an Anti-Cancer Cationic Antimicrobial Peptide and its Complexation to Platinum(II) (2013) (4)
- CHAPTER 1. Enhancing the Therapeutic Potential of Platinum-based Anticancer Agents by Incorporating Clinically Approved Drugs as Ligands (2019) (3)
- A. Sigel, H. Sigel, R. K. O. Sigel (Eds): Interrelations between essential metal ions and human diseases. Vol. 13 of Metal ions in life sciences (2014) (3)
- "Integrated, interprofessional education for first year undergraduate medical, physiotherapy and pharmacy students" (2011) (1)
- Multi-Targeted Metallo-Ciprofloxacin Derivatives Rationally Designed and Developed to Overcome Antimicrobial Resistance. (2021) (1)
- Book review (2018) (0)
- University of Birmingham A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — Anti-proliferative and anti-microbial activity (2016) (0)
- Targeted Metallo-Drugs (2023) (0)
- Book review (2020) (0)
This paper list is powered by the following services:
Other Resources About Celine Marmion
What Schools Are Affiliated With Celine Marmion?
Celine Marmion is affiliated with the following schools: